Literature DB >> 18444862

Strain-relatedness of methicillin-resistant Staphylococcus aureus isolates recovered from patients with repeated infection.

Susan S Huang1, Daniel J Diekema, David K Warren, Gianna Zuccotti, Patricia L Winokur, Shailesh Tendolkar, Linda Boyken, Rupak Datta, Rebecca M Jones, Melissa A Ward, Tanya Aubrey, Andrew B Onderdonk, Christian Garcia, Richard Platt.   

Abstract

Invasive disease following methicillin-resistant Staphylococcus aureus (MRSA) detection is common, regardless of whether initial detection involves colonization or infection. We assessed the genetic relatedness of isolates obtained > or =2 weeks apart representing either repeated infections or colonization-infection sets to determine if infections are likely to be caused by previously harbored strains. We found that MRSA infection following initial colonization or infection is caused by the same strain in most cases, suggesting that a single successful attempt at decolonization may prevent the majority of later infection.

Entities:  

Mesh:

Year:  2008        PMID: 18444862      PMCID: PMC2723744          DOI: 10.1086/529381

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  26 in total

1.  Multiplex PCR strategy for rapid identification of structural types and variants of the mec element in methicillin-resistant Staphylococcus aureus.

Authors:  Duarte C Oliveira; Hermínia de Lencastre
Journal:  Antimicrob Agents Chemother       Date:  2002-07       Impact factor: 5.191

2.  Randomized controlled trial of chlorhexidine gluconate for washing, intranasal mupirocin, and rifampin and doxycycline versus no treatment for the eradication of methicillin-resistant Staphylococcus aureus colonization.

Authors:  Andrew E Simor; Elizabeth Phillips; Allison McGeer; Ana Konvalinka; Mark Loeb; H Rosalyn Devlin; Alex Kiss
Journal:  Clin Infect Dis       Date:  2006-12-14       Impact factor: 9.079

3.  Use of a Staphylococcus aureus conjugate vaccine in patients receiving hemodialysis.

Authors:  Henry Shinefield; Steven Black; Ali Fattom; Gary Horwith; Scott Rasgon; Juan Ordonez; Hock Yeoh; David Law; John B Robbins; Rachel Schneerson; Larry Muenz; Steve Fuller; Joanie Johnson; Bruce Fireman; Harry Alcorn; Robert Naso
Journal:  N Engl J Med       Date:  2002-02-14       Impact factor: 91.245

4.  Nasal carriage as a source of Staphylococcus aureus bacteremia. Study Group.

Authors:  C von Eiff; K Becker; K Machka; H Stammer; G Peters
Journal:  N Engl J Med       Date:  2001-01-04       Impact factor: 91.245

5.  Genetic relatedness of multidrug-resistant, methicillin (oxacillin)-resistant Staphylococcus aureus bloodstream isolates from SENTRY Antimicrobial Resistance Surveillance Centers worldwide, 1998.

Authors:  D J Diekema; M A Pfaller; J Turnidge; J Verhoef; J Bell; A C Fluit; G V Doern; R N Jones
Journal:  Microb Drug Resist       Date:  2000       Impact factor: 3.431

6.  Randomized, placebo-controlled, double-blind trial to evaluate the efficacy of mupirocin for eradicating carriage of methicillin-resistant Staphylococcus aureus.

Authors:  S Harbarth; S Dharan; N Liassine; P Herrault; R Auckenthaler; D Pittet
Journal:  Antimicrob Agents Chemother       Date:  1999-06       Impact factor: 5.191

7.  Carriage of multiple subtypes of methicillin-resistant Staphylococcus aureus by intensive care unit patients.

Authors:  Megan S C Lim; Caroline L Marshall; Denis Spelman
Journal:  Infect Control Hosp Epidemiol       Date:  2006-09-18       Impact factor: 3.254

8.  Molecular epidemiology of methicillin-resistant Staphylococcus aureus in a Veterans Administration Medical Center.

Authors:  Loreen A Herwaldt; Jean M Pottinger; Stacy Coffman; Jean Tjaden
Journal:  Infect Control Hosp Epidemiol       Date:  2002-09       Impact factor: 3.254

9.  Phase 1/2 double-blind, placebo-controlled, dose escalation, safety, and pharmacokinetic study of pagibaximab (BSYX-A110), an antistaphylococcal monoclonal antibody for the prevention of staphylococcal bloodstream infections, in very-low-birth-weight neonates.

Authors:  Leonard E Weisman; Helen M Thackray; Joseph A Garcia-Prats; Mirjana Nesin; Joseph H Schneider; Jennifer Fretz; John F Kokai-Kun; James J Mond; William G Kramer; Gerald W Fischer
Journal:  Antimicrob Agents Chemother       Date:  2009-04-20       Impact factor: 5.191

10.  Intranasal mupirocin to prevent postoperative Staphylococcus aureus infections.

Authors:  Trish M Perl; Joseph J Cullen; Richard P Wenzel; M Bridget Zimmerman; Michael A Pfaller; Deborah Sheppard; Jennifer Twombley; Pamela P French; Loreen A Herwaldt
Journal:  N Engl J Med       Date:  2002-06-13       Impact factor: 91.245

View more
  19 in total

1.  High levels of antibody to panton-valentine leukocidin are not associated with resistance to Staphylococcus aureus-associated skin and soft-tissue infection.

Authors:  Christina R Hermos; Pauline Yoong; Gerald B Pier
Journal:  Clin Infect Dis       Date:  2010-10-14       Impact factor: 9.079

2.  Molecular Epidemiology of Recurrent Cutaneous Methicillin-Resistant Staphylococcus aureus Infections in Children.

Authors:  Duha Al-Zubeidi; Carey-Ann D Burnham; Patrick G Hogan; Rachel Collins; David A Hunstad; Stephanie A Fritz
Journal:  J Pediatric Infect Dis Soc       Date:  2013-07-30       Impact factor: 3.164

3.  Natural antibodies in normal human serum inhibit Staphylococcus aureus capsular polysaccharide vaccine efficacy.

Authors:  David Skurnik; Andrea Kropec; Damien Roux; Christian Theilacker; Johannes Huebner; Gerald B Pier
Journal:  Clin Infect Dis       Date:  2012-07-17       Impact factor: 9.079

Review 4.  Methicillin-resistant Staphylococcus aureus: an overview of basic and clinical research.

Authors:  Nicholas A Turner; Batu K Sharma-Kuinkel; Stacey A Maskarinec; Emily M Eichenberger; Pratik P Shah; Manuela Carugati; Thomas L Holland; Vance G Fowler
Journal:  Nat Rev Microbiol       Date:  2019-04       Impact factor: 60.633

5.  Animal and human antibodies to distinct Staphylococcus aureus antigens mutually neutralize opsonic killing and protection in mice.

Authors:  David Skurnik; Massimo Merighi; Martha Grout; Mihaela Gadjeva; Tomas Maira-Litran; Maria Ericsson; Donald A Goldmann; Susan S Huang; Rupak Datta; Jean C Lee; Gerald B Pier
Journal:  J Clin Invest       Date:  2010-08-25       Impact factor: 14.808

Review 6.  Will there ever be a universal Staphylococcus aureus vaccine?

Authors:  Gerald B Pier
Journal:  Hum Vaccin Immunother       Date:  2013-06-21       Impact factor: 3.452

7.  Functional antibodies targeting IsaA of Staphylococcus aureus augment host immune response and open new perspectives for antibacterial therapy.

Authors:  Udo Lorenz; Birgit Lorenz; Tim Schmitter; Karin Streker; Christian Erck; Jürgen Wehland; Joachim Nickel; Bastian Zimmermann; Knut Ohlsen
Journal:  Antimicrob Agents Chemother       Date:  2010-10-18       Impact factor: 5.191

8.  Antibody-mediated enhancement of community-acquired methicillin-resistant Staphylococcus aureus infection.

Authors:  Pauline Yoong; Gerald B Pier
Journal:  Proc Natl Acad Sci U S A       Date:  2010-01-19       Impact factor: 11.205

9.  Staphylococcal enterotoxin P predicts bacteremia in hospitalized patients colonized with methicillin-resistant Staphylococcus aureus.

Authors:  Michael S Calderwood; Christopher A Desjardins; George Sakoulas; Robert Nicol; Andrea Dubois; Mary L Delaney; Ken Kleinman; Lisa A Cosimi; Michael Feldgarden; Andrew B Onderdonk; Bruce W Birren; Richard Platt; Susan S Huang
Journal:  J Infect Dis       Date:  2013-09-16       Impact factor: 5.226

10.  The pneumococcal pilus predicts the absence of Staphylococcus aureus co-colonization in pneumococcal carriers.

Authors:  Gili Regev-Yochay; Marc Lipsitch; Alan Basset; Ethan Rubinstein; Ron Dagan; Meir Raz; Richard Malley
Journal:  Clin Infect Dis       Date:  2009-03-15       Impact factor: 9.079

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.